VAERS reports by lot

Merck HPV lot 1780876: VAERS reports

180 VAERS reports list lot 1780876 as a Merck HPV vaccine, received between 2022-06-13 and 2024-05-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
180
Reports
0%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1134%
Musculoskeletal412%
Dermatological (non-injection-site)412%
Injection-site / Local reaction412%
Cardiac / Cardiovascular39%
General / Systemic (non-local)39%
Allergic / Anaphylactic26%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois152
Texas8
Florida3
Michigan2
Connecticut2
Pennsylvania2
California1
Tennessee1
Maryland1
Georgia1
Kentucky1
New York1

Reports by month received

2022-062
2022-076
2022-089
2022-092
2022-102
2022-121
2023-032
2023-05143
2023-067
2023-092
2023-111
2024-011
2024-021
2024-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.